FYERS
Home
/
Stocks
/
Results
/
Solara Active Pharma Sciences Results

Solara Active Pharma Sciences Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--3%-2%7%
----1472%
--16%24%-7%
-2%-10%-16%-1%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
SOLARA
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,901.9₹456833 Cr37.7712.0762.82₹11479 Cr
9,186₹245426 Cr83.9134.04128.41₹2568 Cr
4,859.5₹187320 Cr85.8916.7297.06₹2163 Cr
1,132₹113217 Cr25.099.4262.53₹5040 Cr
1,380.6₹112212 Cr33.299.7757.87₹3879 Cr
1,851.4₹101155 Cr92.526.829.25₹889 Cr
2,123₹97626 Cr17.6630.95154.36₹5333 Cr
2,336₹96859 Cr47.4213.7571.08₹1913 Cr
1,161.8₹96406 Cr29.925.3263.99₹4196 Cr
1,657.1₹93614 Cr25.2217.9596.84₹3505 Cr
638.3₹3040 Cr—3.3920.97-₹7 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹382 Cr₹387 Cr₹349 Cr₹314 Cr₹319 Cr₹273 Cr₹300 Cr₹347 Cr₹363 Cr₹299 Cr₹212 Cr₹425 Cr₹352 Cr₹381 Cr₹395 Cr₹338 Cr₹330 Cr₹361 Cr₹100 Cr₹402 Cr₹406 Cr₹444 Cr₹427 Cr₹398 Cr₹348 Cr₹297 Cr₹344 Cr₹351 Cr₹330 Cr₹385 Cr₹356 Cr₹342 Cr₹303 Cr
₹3 Cr₹5 Cr₹0₹49 L₹98 L₹6 Cr₹1 Cr₹32 L₹56 L₹2 Cr₹45 L₹1 Cr₹2 Cr₹5 Cr₹7 Cr₹4 Cr₹7 Cr₹6 Cr₹5 Cr₹3 Cr₹6 Cr₹10 Cr₹8 Cr₹6 Cr₹5 Cr₹12 Cr₹6 Cr₹5 Cr₹4 Cr₹7 Cr₹4 Cr₹1 Cr₹48 L
₹384 Cr₹392 Cr₹349 Cr₹314 Cr₹320 Cr₹279 Cr₹302 Cr₹347 Cr₹364 Cr₹301 Cr₹212 Cr₹426 Cr₹354 Cr₹385 Cr₹402 Cr₹342 Cr₹337 Cr₹367 Cr₹105 Cr₹405 Cr₹411 Cr₹454 Cr₹435 Cr₹404 Cr₹353 Cr₹309 Cr₹350 Cr₹356 Cr₹335 Cr₹392 Cr₹360 Cr₹344 Cr₹303 Cr
₹346 Cr₹356 Cr₹337 Cr₹303 Cr₹286 Cr₹252 Cr₹267 Cr₹311 Cr₹347 Cr₹315 Cr₹400 Cr₹414 Cr₹359 Cr₹358 Cr₹378 Cr₹339 Cr₹346 Cr₹375 Cr₹226 Cr₹358 Cr₹342 Cr₹373 Cr₹349 Cr₹328 Cr₹291 Cr₹271 Cr₹290 Cr₹307 Cr₹289 Cr₹344 Cr₹315 Cr₹314 Cr₹276 Cr
₹65 Cr₹62 Cr₹37 Cr₹35 Cr₹58 Cr₹51 Cr₹59 Cr₹62 Cr₹42 Cr₹11 Cr-₹161 Cr₹39 Cr₹21 Cr₹53 Cr₹52 Cr₹31 Cr₹20 Cr₹20 Cr-₹92 Cr₹75 Cr₹97 Cr₹109 Cr₹114 Cr₹104 Cr₹88 Cr₹62 Cr₹84 Cr₹73 Cr₹68 Cr₹71 Cr₹66 Cr₹49 Cr₹47 Cr
₹22 Cr₹28 Cr₹22 Cr₹21 Cr₹24 Cr₹29 Cr₹27 Cr₹28 Cr₹31 Cr₹31 Cr₹25 Cr₹24 Cr₹25 Cr₹22 Cr₹24 Cr₹22 Cr₹23 Cr₹21 Cr₹18 Cr₹17 Cr₹19 Cr₹25 Cr₹20 Cr₹19 Cr₹20 Cr₹20 Cr₹19 Cr₹20 Cr₹19 Cr₹22 Cr₹23 Cr₹20 Cr₹18 Cr
₹16 Cr₹10 Cr-₹17 Cr-₹10 Cr₹11 Cr-₹2 Cr₹8 Cr₹8 Cr-₹13 Cr-₹167 Cr-₹275 Cr-₹17 Cr-₹29 Cr₹5 Cr₹55 L-₹19 Cr-₹31 Cr-₹31 Cr-₹140 Cr₹30 Cr₹50 Cr₹57 Cr₹66 Cr₹57 Cr₹42 Cr₹18 Cr₹41 Cr₹29 Cr₹27 Cr₹26 Cr₹22 Cr₹10 Cr₹9 Cr
₹16 Cr₹10 Cr-₹17 Cr-₹10 Cr₹11 Cr-₹2 Cr₹8 Cr₹8 Cr-₹13 Cr-₹255 Cr-₹275 Cr-₹17 Cr-₹19 Cr₹4 Cr₹43 L-₹10 Cr-₹16 Cr₹2 Cr-₹140 Cr₹30 Cr₹50 Cr₹57 Cr₹66 Cr₹57 Cr₹42 Cr₹18 Cr₹41 Cr₹29 Cr₹27 Cr₹26 Cr₹22 Cr₹9 Cr₹3 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
—————————
₹45 Cr₹40 Cr₹36 Cr₹36 Cr₹36 Cr₹36 Cr₹27 Cr₹26 Cr₹25 Cr
₹5 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹4 Cr₹101 Cr₹106 Cr₹0
₹1203 Cr₹1051 Cr₹896 Cr₹1463 Cr₹1488 Cr₹1549 Cr₹958 Cr₹824 Cr₹739 Cr
₹1203 Cr₹1051 Cr₹896 Cr₹1463 Cr₹1488 Cr₹1549 Cr₹958 Cr₹824 Cr₹739 Cr
₹1253 Cr₹1094 Cr₹934 Cr₹1500 Cr₹1525 Cr₹1589 Cr₹1086 Cr₹956 Cr₹764 Cr
₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹110 Cr₹114 Cr₹106 Cr₹235 Cr₹283 Cr₹155 Cr₹233 Cr₹225 Cr₹243 Cr
₹0₹0₹0-₹79 Cr-₹55 Cr-₹26 Cr₹12 Cr₹33 Cr₹48 Cr
₹19 Cr₹18 Cr₹12 Cr₹12 Cr₹34 Cr₹41 Cr₹56 Cr₹58 Cr₹25 L
₹53 Cr₹59 Cr₹54 Cr₹49 Cr₹37 Cr₹37 Cr₹33 Cr₹29 Cr₹24 Cr
₹183 Cr₹191 Cr₹172 Cr₹217 Cr₹299 Cr₹206 Cr₹333 Cr₹344 Cr₹315 Cr
—————————
₹274 Cr₹248 Cr₹313 Cr₹306 Cr₹276 Cr₹309 Cr₹216 Cr₹244 Cr₹313 Cr
₹105 Cr₹121 Cr₹168 Cr₹144 Cr₹174 Cr₹117 Cr₹157 Cr₹192 Cr₹90 Cr
₹501 Cr₹573 Cr₹760 Cr₹649 Cr₹610 Cr₹361 Cr₹354 Cr₹214 Cr₹330 Cr
₹14 Cr₹2 Cr₹2 Cr₹2 Cr₹4 Cr₹2 Cr₹3 Cr₹4 Cr₹5 Cr
₹894 Cr₹944 Cr₹1243 Cr₹1101 Cr₹1063 Cr₹789 Cr₹730 Cr₹656 Cr₹738 Cr
₹2333 Cr₹2232 Cr₹2351 Cr₹2821 Cr₹2890 Cr₹2588 Cr₹2153 Cr₹1960 Cr₹1821 Cr
₹564 Cr₹60 Cr₹60 Cr₹4 Cr₹3 Cr₹6 Cr₹5 Cr₹6 Cr₹8 Cr
₹665 Cr₹776 Cr₹999 Cr₹1001 Cr₹1025 Cr₹607 Cr₹707 Cr₹538 Cr₹633 Cr
—————————
₹2038 Cr₹1896 Cr₹1876 Cr₹1868 Cr₹1760 Cr₹1675 Cr₹1581 Cr₹1309 Cr₹1100 Cr
₹801 Cr₹705 Cr₹611 Cr₹528 Cr₹429 Cr₹318 Cr₹213 Cr₹121 Cr₹36 Cr
₹1238 Cr₹1191 Cr₹1266 Cr₹1340 Cr₹1332 Cr₹1356 Cr₹1368 Cr₹1189 Cr₹1063 Cr
₹205 Cr₹280 Cr₹256 Cr₹238 Cr₹239 Cr₹88 Cr₹40 Cr₹40 Cr₹71 Cr
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹42 L₹42 L₹32 L₹41 L₹81 L
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹42 L₹42 L₹32 L₹41 L₹81 L
₹30 Cr₹28 Cr₹24 Cr₹29 Cr₹55 Cr₹59 Cr₹41 Cr₹36 Cr₹46 Cr
₹30 L₹43 L₹48 L₹51 L₹48 L₹1 Cr₹3 Cr₹17 Cr₹9 Cr
₹1474 Cr₹1503 Cr₹1550 Cr₹1633 Cr₹1651 Cr₹1530 Cr₹1481 Cr₹1312 Cr₹1214 Cr
—————————
₹3 Cr₹0₹0₹0₹0₹0₹0₹0₹0
₹318 Cr₹318 Cr₹360 Cr₹558 Cr₹576 Cr₹295 Cr₹280 Cr₹214 Cr₹188 Cr
₹439 Cr₹327 Cr₹349 Cr₹537 Cr₹490 Cr₹484 Cr₹227 Cr₹289 Cr₹263 Cr
₹50 Cr₹4 Cr₹9 Cr₹9 Cr₹47 Cr₹199 Cr₹57 Cr₹76 Cr₹47 Cr
₹20 Cr₹29 Cr₹19 Cr₹23 Cr₹18 Cr₹73 Cr₹40 Cr₹49 Cr₹75 Cr
₹29 Cr₹52 Cr₹52 Cr₹60 Cr₹109 Cr₹7 Cr₹69 Cr₹20 Cr₹35 Cr
₹858 Cr₹729 Cr₹788 Cr₹1188 Cr₹1239 Cr₹1058 Cr₹672 Cr₹648 Cr₹608 Cr
-₹36 Cr-₹215 Cr-₹455 Cr₹86 Cr₹176 Cr₹269 Cr-₹58 Cr-₹7 Cr-₹130 Cr
₹2333 Cr₹2232 Cr₹2351 Cr₹2821 Cr₹2890 Cr₹2588 Cr₹2153 Cr₹1960 Cr₹1821 Cr
₹280₹271₹259₹416₹423₹441₹367₹330₹310
₹280₹271₹239₹384₹390₹407₹338₹330₹310

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
-₹7 Cr₹54 L-₹488 Cr-₹45 Cr-₹91 Cr₹222 Cr₹115 Cr₹58 Cr₹20 L
₹201 Cr₹210 Cr₹406 Cr₹187 Cr₹181 Cr₹173 Cr₹168 Cr₹148 Cr₹63 Cr
-₹38 Cr₹3 Cr₹191 Cr₹74 L-₹314 Cr-₹206 Cr-₹16 Cr-₹25 Cr-₹11 Cr
₹155 Cr₹214 Cr₹108 Cr₹143 Cr-₹224 Cr₹189 Cr₹266 Cr₹181 Cr₹52 Cr
₹153 Cr₹213 Cr₹109 Cr₹156 Cr-₹242 Cr₹155 Cr₹242 Cr₹166 Cr₹49 Cr
-₹99 Cr-₹37 Cr-₹4 Cr-₹81 Cr-₹243 Cr-₹106 Cr-₹359 Cr-₹116 Cr-₹85 Cr
-₹54 Cr-₹180 Cr-₹106 Cr-₹113 Cr₹334 Cr₹92 Cr₹97 Cr-₹23 Cr₹68 Cr
₹53 L-₹4 Cr-₹29 L-₹38 Cr-₹151 Cr₹142 Cr-₹20 Cr₹27 Cr₹31 Cr
₹4 Cr₹8 Cr₹9 Cr₹46 Cr₹198 Cr₹56 Cr₹76 Cr₹46 Cr₹0
₹0₹0₹0₹0₹0₹0₹0₹3 Cr₹14 Cr
₹4 Cr₹4 Cr₹8 Cr₹9 Cr₹46 Cr₹198 Cr₹56 Cr₹76 Cr₹46 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)628.00
Volume (₹)2.67 L
High (₹)652.00
Upper Circuit755.80
Low (₹)619.00
Lower Circuit503.90
Prev Close629.85
52W High (₹)712.00
Price638.30
52W Low (₹)422.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)3040.02 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.53
Price to Book1.52
Book Value280.27
EPS (TTM)-0.34
Face Value10.00
ROE (%)-0.63

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
SOLARANSE
LTP
1W Low
1W High
Market cap (₹)
1901.9-18.1 (-0.94%)
1900.10
1984.80
4,56,833Cr
9186-53 (-0.57%)
9087
9467
2,45,426Cr
4859.5-190.5 (-3.77%)
4857
5066
1,87,320Cr
1132-59 (-4.95%)
1125.10
1187
1,13,217Cr
1380.6-42.9 (-3.01%)
1376.70
1426.10
1,12,212Cr
1851.4-87.1 (-4.49%)
1811.70
1949
1,01,155Cr
2123-48.5 (-2.23%)
2118.10
2192
97,626Cr
2336-46.9 (-1.97%)
2335
2419.20
96,859Cr
1161.8-16.2 (-1.38%)
1154.40
1179.90
96,406Cr
1657.1+11.8 (0.72%)
1622.60
1717
93,614Cr
638.3+14.6 (2.34%)
615.35
674
3,040Cr

Solara Active Pharma Sciences Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹64.66Cr; with other income of ₹2.69Cr, profit before interest and tax came to ₹37.95Cr. Interest expense was ₹21.64Cr; PBT before exceptional items stood at ₹16.31Cr. Cost mix (full year): raw materials ₹676.26Cr; employee cost ₹219.2Cr; depreciation ₹26.71Cr; other expenses ₹319.63Cr. Basis: consolidated annual results.

Solara Active Pharma Sciences Ltd Quaterly Results Key Takeaways

Solara Active Pharma Sciences Ltd reported ₹381.6Cr total income from operations in Jun 2026, softer than ₹387.29Cr in Mar 2026 but higher than ₹319.15Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹64.66Cr; with other income of ₹2.69Cr, profit before interest and tax came to ₹37.95Cr. Interest expense was ₹21.64Cr, taking profit before tax to ₹16.31Cr. After tax of ₹0 cr, profit after tax stood at ₹16.31Cr (vs ₹9.6Cr in Mar 2026 and ₹10.52Cr in Jun 2025).